difference between tirzepatide and semaglutide for weight loss vs Tirzepatide: Key Differences Tirzepatide vs. Semaglutide: A Complete

10.1210/jcem-69-3-654 21

Safety: what we know, what we dont What clinical trial safety reviews suggest The clinical safety review literature reports several reassuring signals: No meaningful increase in IGF-1 in monitored long-term studies (jofem.org) No clear negative effect on carbohydrate metabolism in testing described (contrast with full hGH) (jofem.org) No clear immunogenicity signal (e.g., anti-AOD antibodies) in the subset assessed in those trials (jofem.org) The major limitation: long-term real-world certainty is thin The problem with many peptides is not that everything is dangerousits that the certainty level is often lower than patients assume

Glucagon-like peptide-2

Even though the risk of thyroid cancer with the use of GLP-1 agonists is small, lets assume for a minute that it is large

FAQ Are GLP-1 drugs an American phenomenon or a global signal

These medications work by increasing feelings of fullness by slowing the rate at which the stomach empties, which can help reduce the urge to overeat